Noblestitch® system for PFO closure: A novel but judicious alternative to traditional devices-A case report.
atrial septal tear
patent foramen ovale
residual shunt
suture-based PFO closure
transcatheter closure
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
11
11
2022
accepted:
13
03
2023
medline:
18
4
2023
entrez:
17
4
2023
pubmed:
18
4
2023
Statut:
epublish
Résumé
Percutaneous suture-mediated patent foramen ovale (PFO) closure has recently been used with the aim of avoiding double-disc nitinol device implantation. This novel technique has been carried out successfully in several centers offering PFO closure with an effective closure rate comparable to conventional double-disc devices. A 50-year-old man, a pentathlon athlete, suffering from a previous left-sided ischemic stroke, underwent percutaneous closure of a permanent right-to-left shunt Closing a PFO with a suture-base system, without leaving a device implant behind, may be a cutting-edge technology and potential alternative to traditional devices. Nevertheless, meticulous selection of the PFO anatomies by 2D TEE is key to a successful closure procedure in order to avoid complications that must be managed again with a second percutaneous procedure or by surgery.
Sections du résumé
Background
UNASSIGNED
Percutaneous suture-mediated patent foramen ovale (PFO) closure has recently been used with the aim of avoiding double-disc nitinol device implantation. This novel technique has been carried out successfully in several centers offering PFO closure with an effective closure rate comparable to conventional double-disc devices.
Case summary
UNASSIGNED
A 50-year-old man, a pentathlon athlete, suffering from a previous left-sided ischemic stroke, underwent percutaneous closure of a permanent right-to-left shunt
Discussion
UNASSIGNED
Closing a PFO with a suture-base system, without leaving a device implant behind, may be a cutting-edge technology and potential alternative to traditional devices. Nevertheless, meticulous selection of the PFO anatomies by 2D TEE is key to a successful closure procedure in order to avoid complications that must be managed again with a second percutaneous procedure or by surgery.
Identifiants
pubmed: 37063961
doi: 10.3389/fcvm.2023.1095661
pmc: PMC10097917
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1095661Informations de copyright
© 2023 Onorato, Grancini, Monizzi, Mastrangelo, Fabbiocchi and Bartorelli.
Déclaration de conflit d'intérêts
EO is consultant for Occlutech, manufacturer of the device. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
EuroIntervention. 2018 Jun 08;14(3):e272-e279
pubmed: 29616629
N Engl J Med. 2017 Sep 14;377(11):1011-1021
pubmed: 28902593
Int J Environ Res Public Health. 2022 Jun 27;19(13):
pubmed: 35805522
JACC Cardiovasc Interv. 2019 Aug 26;12(16):e139-e140
pubmed: 31377272
N Engl J Med. 2017 Sep 14;377(11):1022-1032
pubmed: 28902590
EuroIntervention. 2022 May 15;18(1):68-70
pubmed: 35403602
JACC Cardiovasc Interv. 2020 Sep 28;13(18):2112-2120
pubmed: 32972572
N Engl J Med. 2017 Sep 14;377(11):1033-1042
pubmed: 28902580
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):638-642
pubmed: 32315110
Eur Heart J Case Rep. 2020 Aug 23;4(5):1-4
pubmed: 33204941